XML 35 R11.htm IDEA: XBRL DOCUMENT v3.20.4
Balance Sheet Components
12 Months Ended
Dec. 31, 2020
Balance Sheet Components [Abstract]  
Balance Sheet Components NOTE 5. BALANCE SHEET COMPONENTS

Inventory

As of December 31, 2020 and 2019, our inventory consisted of the following components:

December 31,

December 31,

(in thousands)

2020

2019

Purchased materials

$

3,531

$

3,966

Work in process

6,651

4,594

Finished goods

4,048

4,752

Inventory

$

14,230

$

13,312

Property and Equipment, Net

As of December 31, 2020 and 2019, our property and equipment, net, consisted of the following components:

December 31,

(in thousands)

2020

2019

Laboratory equipment and machinery

$

24,948

$

25,173

Leasehold improvements

29,931

29,902

Computer equipment

12,400

11,851

Software

4,940

4,747

Furniture and fixtures

2,434

2,422

Construction in progress

137

193

74,790

74,288

Less: Accumulated depreciation

(49,891)

(44,218)

Property and equipment, net

$

24,899

$

30,070

Depreciation expense during the years ended December 31, 2020, 2019 and 2018 was $6.4 million, $7.3 million and $7.2 million, respectively.

Accrued Expenses

As of December 31, 2020 and 2019, our accrued expenses consisted of the following components:

December 31,

(in thousands)

2020

2019

Salaries and benefits

$

15,261

$

9,748

Accrued product development costs

415

67

Accrued Tenant Improvements for Menlo Park building

998

Inventory accrual

218

229

Accrued professional services and legal fees

726

943

Other

730

1,257

Accrued expenses

$

17,350

$

13,242

Deferred Revenue

As of December 31, 2020, we had a total of $10.3 million of deferred revenue from our service contracts, $8.7 million of which was recorded as “Deferred revenue, current” to be recognized over the next year and the remaining $1.6 million was recorded as “Deferred revenue, non-current” to be recognized in the next 3 years. Revenue recorded in the year ended December 31, 2020 includes $7.6 million, respectively, of previously deferred revenue that was included in “Deferred revenue, current” as of December 31, 2019. Contract assets as of December 31, 2020 and December 31, 2019 were not material.

As of December 31, 2020, we had a total of $0.7 million of deferred commissions included in “Prepaid expenses and other current assets” which is recognized as the related revenue is recognized. Additionally, as a practical expedient, we expense costs to obtain a contract as incurred if the amortization period would have been a year or less.

Notes payable, current

As of December 31, 2019, a balance of $16.0 million aggregate principal amount of debt remained outstanding under the debt agreement with Deerfield entered into in February 2013 and was presented as “Notes payable, current” on the consolidated balance sheet as of December 31, 2019.

In February 2020, upon the maturity of the debt agreement, we repaid the remaining outstanding principal of $16.0 million and interest.

Financing Derivative

A number of features embedded in the promissory notes required accounting for them as a derivative, including the indemnification of certain withholding taxes and the acceleration of debt upon (i) a qualified financing, (ii) an event of default, (iii) a Major Transaction (as such term is defined in the Facility Agreement), and (iv) the exercise of the warrant via offset to the debt principal. These features represent a single derivative (the “Financing Derivative”) that was bifurcated from the debt instrument and accounted for as a liability at fair value, with changes in fair value between reporting periods recorded in other income (expense), net.

The estimated fair value of the Financing Derivative was determined by comparing the difference between the fair value of the promissory notes with and without the Financing Derivative by calculating the respective present values from future cash flows using a 6.5% discount rate at December 31, 2019. The estimated fair value of the Financing Derivative as of December 31, 2019 was $0.

In February 2020, after we repaid the remaining outstanding principal of $16.0 million and interest to Deerfield, the related Financing Derivative expired.

Other liabilities, current

As of December 31, 2020 and 2019, our Other liabilities, current consisted of the following components:

December 31,

(in thousands)

2020

2019

Accrued ESPP

$

2,037

$

Other

2,482

225

Other liabilities, current

$

4,519

$

225

Pursuant to the terms of the then-in-process Merger Agreement with Illumina, offerings under our 2010 ESPP were suspended after the completion of the purchase period ended March 1, 2019, resulting in the balance for “Accrued ESPP” being $0 as of December 31, 2019. After the merger with Illumina was terminated in January 2020, we began offerings under the ESPP again starting with the offering period beginning March 1, 2020.